ClinicalTrials.gg
RecruitingNCT07364903FINCUpdated Jan 23, 2026

Effectiveness of Family-Integrated Newborn Care to Improve Outcomes for Preterm and Low-birth-weight Neonates

An interventional study of Family Integrated Newborn Care, an intervention to integrate family in the care targeted their preterm and Low-birth weight neonates and Standard medical treatment in Family Involvement/Empowerment, Family-centered Care and Intensive Care Units, Neonatal, sponsored by Laerdal Foundation. Recruiting at 2 sites in Ethiopia. Per ClinicalTrials.gov, last updated 2026-01-23.

Sponsored by Laerdal Foundation · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Dec 2025; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
1,020
Allocation
Non-randomized
Sex
All
01

Study summary

The goal of this quasi-experimental study is to learn if integrating family in newborn care units as a key partner can improve the outcomes of preterm and low-birth-weight neonates. The main question[s] that the study aims to answer:

  • Does the implementation of the FINC intervention impact the neonatal outcomes for preterm and low-birth weight neonates in NCUs in resource-limited settings of Tigray, Northern Ethiopia? Researchers will compare the Length of hospital stay among preterm and low-birth-weight neonates admitted to hospitals included in the intervention groups and compared to the neonates admitted to hospitals in the control group.

In the intervention groups, family of preterm and low-birth-weight neonates will be trained, mentored, and integrated into the care targeted to their neonates.

Read the detailed description

The World Health Organization recommends Family involvement and support in the management of preterm and low birth weight neonates. However, the body of literature on its effectiveness in low-resource settings is scanty. The current study aimed to investigate the effectiveness of implementing Family-Integrated Newborn Care to improve outcomes for preterm and low-birth weight Neonates in resource-limited settings in resource-limited settings of Ethiopia. A quasi-experimental design with non-equivalent comparison groups will be employed among 1020 family-neonate dyads in three hospitals with level-2 Neonatal Care Units. The intervention package will mainly consist of training and education sessions for health care providers and families supplemented by measures to ensure infection prevention in level-2 neonatal care units. The effect size of implementing Family-Integrated Newborn Care on neonatal and parental outcomes will be estimated using General Linear Models (GLM) and compared with the conventional care. Research questions are:

  1. Does the implementation of the FINC intervention impact the neonatal outcomes for preterm and low-birth-weight neonates in NCUs in resource-limited settings of Tigray, Northern Ethiopia?
  2. Was the uptake of implementation of the FINC intervention for preterm and low-birth-weight neonates acceptable?
02

Conditions studied

  • Family Involvement/Empowerment
  • Family-centered Care
  • Intensive Care Units, Neonatal
  • Family Integrated Newborn Care

Browse trials for

03

In context

Empowerment

154 studies on the registry are indexed under Empowerment; 31 are open to participants now.

This study's planned enrollment of 1,020 is above the median of 141 across 132 interventional studies indexed under Empowerment.

Browse Empowerment studies →

Lead sponsor

This is the only study on the registry with Laerdal Foundation as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All neonates aged 0-28 days admitted to level-2 NCUs in the neonatal care unit, including Kangaroo Mother care ward or mothers' side ward, with conditions that require hospital stay at 48 hours; and
  • accompanied by at least one parent (preferably a mother) dedicated to spending up to 8 hours per day with the infant

Exclusion criteria

Exclusion Criteria:

  • Neonates with major congenital anomalies
  • Infants with no family member to accompany the infant, or who do not consent to spend up to 8 hours per day in the NCU
  • Families with confirmed physical and/or mental problems limiting their capability to communicate and to engage, or those who leave against medical advice
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,020 participants (estimated)

Study arms

  • Experimental
    FINC arm

    This arm includes the family of the neonates assigned to the experimental group, and they will receive a FINC intervention. The FINC intervention, families of preterm and low-birth weight neonates aged 0-28 days will be trained, educated, and encouraged to get involved in the newborn care targeted to their neonates.

    Behavioral: Family Integrated Newborn Care, an intervention to integrate family in the care targeted their preterm and Low-birth weight neonates

  • Active comparator
    Non-FINC arm

    This arm includes the families of the neonates assigned to the comparator group, who will receive conventional or standard care. No special effort that the routine care will be provided to integrate the family into the care targeted to the preterm and low-birth-weight neonates

    Behavioral: Standard medical treatment

Interventions

  • BehavioralFamily Integrated Newborn Care, an intervention to integrate family in the care targeted their preterm and Low-birth weight neonates

    The Family Integrated Newborn Care intervention includes undergoing 1) minor modifications in the NCU space and physical infrastructure conducive to family integration; 2) bedside training for families, and 3) provision of ten audio-visual materials in the local language (Tigrigna) demonstrating family integration in key caring activities targeted to their neonates.

    Also known as: Family-Centered care, Family Involvement

  • BehavioralStandard medical treatment

    The preterm and low-birth weight neonates will receive the conventional care with no special attention to integrate the families in the care targeted to the neonates

    Also known as: Conventional newborn care

06

What researchers measure

Primary outcomes

  1. Length of hospital stay

    It refers to the duration a neonate stays in the hospital for care, starting from admission to discharge home

    Time frame: The period from the date of admission to the date of discharge is within the first 28 days of neonat's life.

Secondary outcomes

  1. Survival at discharge

    Survival status of the neonate at discharge, specified as alive, dead, or referred for higher-level care, or left against medical advice.

    Time frame: Starting from date of admission to the date of discharge within the first 28 days of the neonate's life

  2. Daily weight gain

    The net weight gain of a neonate each day (in grams/kg/day) in reference to the expected gain for the body mass

    Time frame: Starting from the date of admission up to the date of discharge and assessed in the first 28 days of the neonate's life

  3. Time to initiate breastfeeding after admission

    The time the breastfeeding of the neonate is initiated for the first time since admission

    Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life

  4. Time to initiate skin-to-skin after admission

    The first time skin-to-skin is initiated for the neonate, since the date of admission to the Neonatal Intensive Care Unit (NICU)

    Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life

  5. The number of days on Antibiotics

    The total number of days the neonate received antibiotics for being suspected or diagnosed with sepsis

    Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life

  6. Score for parental stress monitoring scale

    A score for the parental stress monitoring scale, which consists of eight items in a five-point Likert scale, with scores ranging from a lower score (1= Not stressful at all) to a higher score (5= Extremely stressful).

    Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life

  7. Discharge readiness score on the day of the discharge

    The score for the discharge readiness scale, consisting of eight items in a five-point Likert scale, to assess parents' readiness at the time of discharge. The score level ranges from a lower score (1= Extremely low confidence) to a higher score (5= Extremely high confidence).

    Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life

07

Study locations

1 of 2 sites recruiting
  • Mekelle General Hospital, Wukro General Hospital and Adigrat General Hospital
    Mek'ele, Tigray 1871, Ethiopia
    Recruiting
    • Znabu Hadush Kahsay, MPH, PhD student · Contacthadiszinabu@gmail.com · 0920874140
    • Araya Abrha Dr.Medhanyie, PhD · Contactaraya.medhanyie@gmail.com · +251 933222222
    • Znabu Hadush Kahsay, MPH, PhD studnet · Principal investigator
    • Araya Abrha Medhanyie, PhD · Sub investigator
  • Mekelle General Hospital, Wukro General Hospital and Adigrat General Hospital
    Mek'ele, Tigray 1871, Ethiopia
    Not yet recruiting
08

References and documents

Publications

  • Kahsay ZH, Medhanyie AA, Mariam DH, Ersdal HL, Rettedal S. Feasibility of implementing family-integrated newborn care for hospitalised preterm and low birthweight infants in newborn care units of Ethiopia: a mixed-methods design. BMJ Open. 2025 Jan 21;15(1):e093377. doi: 10.1136/bmjopen-2024-093377. PubMed 39842933 ↗

Individual participant data

Plan to share: Yes — The study is part of a PhD study. The dataset consists of inpatient data will be shared after the manuscript summarizing the key findings of the trial is published. Hence, the dataset will be made available open for the public in June 2027. In addition, the IPD can be shared up on reasonable request form the contact person of the study.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: June 2027, one year after the completion of the trial

Access criteria: The IPD will be available in the data repository for Mekelle University based on the notification to the contact person of the study

Data sharing details ↗ · repository.mu.edu.et

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Jun 2026, 5 months after the start.

Of 82 non-industry interventional studies with no phase under Empowerment, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 5 months is below that.

Counting every sponsor, half of 82 studies reached it within 22 months; a quarter within 11 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2025
First posted
Jan 23, 2026
StartActual
Dec 16, 2025
Primary completionEst.
Jun 15, 2026
CompletionEst.
Jun 16, 2026
Last update
Jan 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07364903
Lead sponsor
Laerdal Foundation
Collaborators
Mekelle University, Addis Ababa University
Responsible party
Znabu Hadush Kahsay (Principal Investigator, University of Stavanger) — Principal investigator
First posted
Jan 23, 2026
Start date
Dec 16, 2025
Primary completion
Jun 15, 2026 (estimated)
Completion
Jun 16, 2026 (estimated)
Last update
Jan 23, 2026

Study contacts

Znabu Hadush Mr.Kahsay, MPH, PhD student
Contact
znabu.hadish@mu.edu.et
+251 1920874140
Araya Abrha Dr.Medhanyie, PhD
Contact
araya.medhanyie@gmail.com
+251933222222
Siren Rettedal, MD, PhD
study chair · 1. Faculty of Health Sciences, University of Stavanger, Stavanger, Norway 2. Department of Simulation-based learning, Stavanger University Hospital, Norway
Hege Prof.Ersdal, MD, PhD
study director · hege.ersdal@safer.net
Damen Hailemariam, MD, PhD
study director · damengoog@gmail.com

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion